据美国FDA消息，5月7日美国FDA发布豁免标示过敏原申请及通知的行业指南草案，以帮助行业起草豁免过敏标识申请书。
草案称，因为来自主要过敏原的成分可能经过改进，已不含过敏蛋白质或不会引起过敏反应，因此按照美国《食品过敏原标识与消费者保护法案》的要求，可以豁免标识过敏原。
部分原文报道如下：
The U.S. Food and Drug Administration （FDA） is issuing draft guidance, Draft Guidance for Industry: Food Allergen Labeling Exemption Petitions and Notifications1, that is intended to help industry prepare submissions that seek exemptions from the labeling requirements for ingredients derived from major food allergens.
The Food Allergen Labeling and Consumer Protection Act of 2004 （FALCPA） requires that food labels identify products containing major food allergens （milk, eggs, fish, Crustacean shellfish, tree nuts, wheat, peanuts, and soybeans）。 Because an ingredient derived from a major food allergen may be modified to such an extent that it does not contain allergenic protein or does not cause an allergic response that poses a risk to human health, FALCPA provides for two processes through which a manufacturer can obtain an exemption from this labeling requirement for a specific ingredient.
原文链接：http://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm396167.htm
18926578588